Search for: "MS v. AS " Results 1641 - 1660 of 13,911
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Mar 2021, 3:26 am by Chukwuma Okoli
”[5]   Comments There are five comments that could be made about the Court of Appeal’s decision (Hussaini JCA) in A.B.U. v VTLS.[6] First, the Court of Appeal (Hussaini JCA) in A.B.U. v VTLS[7] followed Oputa JSC’s obiter dictum in Sonnar (Nig) Ltd v Partenreedri MS Norwind.[8] It should be stressed that Oputa JSC’s obiter dictum is not binding on lower courts according to the Nigerian common law doctrine of stare decisis. [read post]
9 Mar 2021, 8:32 am
“Saying the word ‘normal’ has been used to set you apart,” Ms. [read post]
8 Mar 2021, 1:17 am by Rose Hughes
Interestingly, a Canadian dosage regime patent to a different MS drug was also recently found not obvious-to-try by the Canadian Federal Court (FCC) (Teva v Pharmascience, 2020 FC 1158, IPKat). [read post]